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Introduction:
neurodegenerative diseases amongst the autosomal-recessive genetic disorders which is 
caused by the absence of protein survival of motor neuron (SMN). A critical nucleotide 
difference in SMN2 compared to SMN
homozygous lack of SMN1 provides a progressive disease. Due to the high prevalence, 
up to now, several molecular diagnostic methods have been used which most of them are 
lengthy, expensive, and laborious. Methods: In the present study, we exploited a gold 
nanoprobe-based method for semi-quantitative SMN1 gene dosage analysis compared 
to SMN2. The assay was done under hybridization process between Au nanoprobes 
and different ratios of SMN1/SMN2 amplicons. Results: UV-vis spectra indicated that 
after the salt addition, nanoprobes aggregated gradually and their peak shifted to longer 
wavelengths except in the stable target-nanoprobes hybridization. The results revealed 
that the homozygous genotype of SMN2 gene is distinguished from the heterozygous 
genotypes of SMN genes by the naked eye, whereas different ratio of heterozygous 
genotypes (SMN1/SMN2) are differentiated better from each other using peak analysis 
ratios. Conclusion: The presented strategy is an alternative simple method for 
discrimination of homozygous deletion of SMN1 in less than 30 min. However, further 
evaluation of the assay using clinical samples is recommended prior to real-world use.
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Introduction
Proximal spinal muscular atrophy (SMA) is one of the most 
the autosomal-recessive genetic disorders.1 This fetal- 
adolescent progressive illness is caused by the absence 
of protein survival of motor neuron (SMN). Homologous 
inverted copies of SMN genes (SMN1 and SMN2), which 
are located on the chromosome 5q13, are responsible for 
protein expression. These copies differ by 5 nucleotide 
base pairs (one in exon 7, exon 8, and intron 6; two in 
intron 7). A critical single nucleotide polymorphism (SNP) 
in exon 7 (840 C>T) leads to the production of defective 
form of SMN2 protein which consequently cannot 
circumvent the role of SMN complex, an assemblyosome 
of ribonucleoproteins.2 As a result, homozygous deletion 
of SMN1, in 94% of SMA cases, leads to a progressive 
neuromuscular disease.3
Due to the high prevalence and carrier frequency (1
in 10,000 and 1 in 50, respectively), up to the present 
time, several molecular diagnostic methods have 
been developed for SMA detection. These techniques 
include: Linkage analysis,4 Polymerase Chain Reaction-
Restriction Fragment Length Polymorphism (PCR-
RFLP),5,6
Polymerase Chain Reaction (ARMS-PCR),7 PCR-single-
strand conformation polymorphism (SSCP) analysis,8
Colorimetric Assay for Exon 7 SMN1/SMN2 Single Nucleotide 
Polymorphism Using Gold Nanoprobes
